INTRODUCTION
Since its first description by Berger and Hinglais in 1968 (1), primary IgA nephropathy has been an etioReceived for publication 4 August 1982 and in revised form 8 December 1982. pathological challenge for nephrologists and immunologists. At the moment, after large numbers of various explorations have been performed both on kidneys and in serum from patients with Berger's disease, a series of well established facts seems to lead towards a better understanding of what happens in this peculiar disease. First, the presence of C3, C9, and occasionally factor B and properdin in the mesangial deposits (2) (3) (4) (5) (6) , together with the pathognomonic IgA, allows to classify Berger's disease as an "immune complex nephritis" (7) . This is in keeping with the reported finding of IgA-containing circulating immune complexes in such patients' serum (8) (9) (10) . Second, serological studies have often evidenced high levels of circulating IgA (3, 5, (8) (9) (10) (11) , independent of the presence of circulating immune complexes, suggesting the existence of some primary abnormality. An imbalance of the IgA system might take place at two levels, according to the systemic or mucosal origin of these immunoglobulins. Frequent observation of recurrent infections of the upper respiratory tract, often occurring prior to renal manifestations, represents the third piece of evidence displaying an etiopathological pattern for Berger's disease.
This hypothesis figures that mesangial IgA may have a mucosal origin, and recently received some support with the demonstration of these IgA polymeric nature (12, 13) . This theory takes account of the serological abnormalities aforementioned, but still needs to be thoroughly supported by pieces of evidence.
Tonsillectomy and dental treatment have been reported as efficient means to prevent an early onset of renal failure (14, 15) . We have investigated the plasma cell populations of tonsils from patients suffering from primary IgA nephropathy who underwent tonsillectomy, providing us with a convenient way of studying a part of their secretory immune system. Seven patients (two females, five males) suffering from IgA nephropathy were included in this study. The average age was 28 yr (range, 17-44). Berger's disease was suggested by clinical and biological findings, and confirmed by immunological study of kidney biopsies. All diagnoses were established in our laboratory, by evidence of mesangial deposits, labeled by fluorescent monospecific antisera to human alpha chains, C3 and C9 (Behring AG, Marburg, FRG). All patients had elevated levels of serum IgA as determined by laser immunonephelometry (mean value 344.5 mg/100 ml, range 253-480 mg/100 ml; reference interval in controls, 130-300 mg/100 ml).
Controls
The control series included seven age-matched males who had undergone tonsillectomy as treatment for recurrent infections of the upper respiratory tract, therefore presenting with the same tonsillar background as the patients. Five were free from renal troubles. Two had minimal signs of renal lesion (mild proteinuria and microscopic hematuria), but immunohistological study of kidney biopsies failed to characterize Berger's disease: one was free from deposits of any kind, the other contained faintly labeled deposits of C3 in the mesangial area, similar to those described by Orfila et al. (16) .
Tissue specimens
A total number of 20 palatine tonsil specimens were studied, since both right and left tonsils were obtained from five patients and one control. They were removed surgically, and each sample was snap-frozen in liquid nitrogen immediately after removal, then kept at -750C until studied.
Immunofluorescence techniques
Serial tissue sections were frozen-cut at 3.5 ,um, the plane of the section being oriented normally to the tonsil's epithelial surface. The first section was stained with toluidine blue (as currently done for frozen-cut material) for orientative histologic analysis. Nine consecutive sections were then collected on clean glass slides, and washed 5 min in phosphate-buffered saline (PBS) at room temperature. Three sections were stained with each of the following fluoresceinconjugated antisera:anti-human gamma, alpha, and mu heavy chains (Behring). These reagents had previously been tested in immunofluorescence on a large number of other human tissues to assess the absence of nonspecific labeling of epithelial or other unconcerned cells. Their monospecificity was also checked by immunofluorescence on bone marrow smears of immunochemically defined myelomas and frozen-cut sections of plasmacytomas. This monospecificity was further confirmed by "blocking experiments" performed on tonsillar sections after incubation of the antiserum with purified aggregated immunoglobulins.
The absence of cross-reactivity was checked by doublelabeling some tonsil sections with fluorescein-conjugated anti-gamma chain serum and rhodamine-conjugated antialpha chain serum (Cappell Laboratories, Cochranville, PA).
The latter specificity had been tested both in immunofluorescence and immunodiffusion. All immunofluorescence tests were performed at room temperature by incubation of the sections with a proper dilution of the adequate antiserum in PBS, in a moist chamber for 30 min. The sections were then mounted in a glycerol/saline mixture (9/1 vol/vol) under a coverslip. All slides were examined in a blind fashion by two different people.
Identification of J chain-producing plasma cells
To evaluate the number of IgA-secreting plasma cells also producing J chain, a technique adapted from this described by Brandtzaeg et al. (17) was used. Briefly, two sections from each tonsil were collected on a clean glass slide and washed in PBS for 5 min at room temperature. The slides were then placed in cold 950 ethanol and fixed at 4°C for 5 min. After another wash in PBS at room temperature the sections were submitted to denaturation in 6 M urea, pH 3.5, for 1 h at 4°C. This treatment was followed by three washes in PBS (5 min, room temperature) to remove all urea from the sections. Three periods of incubation followed, with intervals of three washes in PBS. They were respectively performed with rabbit anti-human J chain serum (Nordic Laboratories, Oslo, Norway) fluorescein-conjugated sheep anti-rabbit IgG serum (Institut Pasteur, Paris, France), and rhodamine-conjugated anti-alpha chains serum.
A series of immunofluorescence and immunochemical tests had assessed the monospecificity of the anti-rabbit IgG serum and of the anti-J chain serum. The latter was further carefully checked as follows: (a) It provided one single peak in double bidimensional electrophoresis against human dimeric IgA purified from colostrum (12) , mildly reduced with thioerythrytol, submitted to electrophoresis with sodium dodecyl sulphate in polyacrylamide gel, and submitted to a cross electrophoresis against an agarose gel containing the anti-J chain serum. (b) J chain labeling was completely "blocked" after incubation of the antiserum with a purified preparation of human J chain checked in polyacrylamide electrophoresis. (c) J chain labeling was not modified after absorption of the antiserum against an immunosorbent prepared with human monomeric serum IgA (12) .
Control slides were prepared for all sections, omitting the anti-J chain serum, which displayed no green fluorescence and assessed the absence of nonspecific labeling by the fluorescein-conjugated anti-rabbit IgG serum.
Immunohistomorphometry
Quantification of IgG, IgA, and lgM-producing cells.
All sections studied contained the four tonsillar compartments described by Brandtzaeg et al. (18) : extrafollicular area, follicle center, mantle zone, and reticular epithelium.
The slides were observed with a Ploem system of epiillumination and selective interferential filters for green and red fluorescence. Table I . Table II ). 1 and r indicate that the following results are related to the left or right tonsil. Table II gives the results considered for statistical analysis, in terms of mean indexes, percentages and standard errors for patients and controls. As mentioned previously, a t test was applied to seven results from each group, random choice providing the recorded data when two samples had been available for one individual.
Results in Table I clearly evidence much higher numbers of IgA-secreting cells than of IgG-producing cells in the patients, while the opposite is observed in the control group. Table II indicates a statistically significant difference (P = 0.001), which likely represents the major result of this study.
However, several other features deserve to be pointed out, such as the degree of imbalance in patients where the mean index value of the most represented Ig class (IgA) is much higher than this of controls' predominant Ig class (IgG). These indexes, respectively, are 11.27 and 9.90. This observation may be extended to the overall tonsillar plasma cells population: when the results of the three classes are pooled, the number of plasma cells per square millimeter is 316 in the control group, and 428 in the patients. These data indicate a higher density of plasma cells in patients' tonsils, and are within a normal range in controls as compared with what has been reported by Brandtzaeg et al. (18) .
Presence of J chain in IgA-secreting cells. The study of doubly labeled sections of the 20 specimens allowed two kinds of observations. First, it demonstrated the presence of two types of IgA-secreting cells, depending on the concomitant presence or absence of J chain. Second, it evidenced a population of cells stained for J chain only. This has been reported previously (20) , but in this case, the intensity of the labeling and the fairly small number of stained cells suggest that IgM-secreting cells were visualized in this indirect manner.
A quantitative analysis of dimeric IgA-secreting 
DISCUSSION
The results presented in this paper are, to our knowledge, the first demonstration of significant mucosal differences between Berger's disease patients and controls.
It shows, in seven patients, a significant increment of the tonsillar dimeric IgA-secreting plasma cell population, associated to a decrease in the IgG-producing plasma cell population. These observations enhance the significance of the abnormalities we noticed in Berger's disease patients. If needed, further support could be found in Surjan and Brandtzaeg results evidencing a decrease in the tonsillar plasma cell population in elder subjects (18) , and in patients with recurrent tonsillitis (27) . We obtained elevated values in our patients who both belong to adulthood and suffer from recurrent infectious episodes of the upper respiratory tract, including tonsillitis.
Some basic abnormality, therefore, seems to be present in these patients' tonsils, the origin of which remains to be demonstrated. A genetic background cannot be excluded, particularly since no specific infectious agent has been reported responsible for these patients' tonsillitis. This suggests an abnormal response to common germs, which might happen because of a B cell dysfunction or, at a different level, imply an imbalance of T cells regulatory subsets, or result from a dysfunction of "switch cells" preferentially leading to an IgA-type response (28) .
As far as Berger's disease etiopathological mechanisms are concerned, this certainly favors the hypothesis of a mucosal origin for mesangial IgA. The excess of dimeric IgA produced as a consequence to tonsillar infection might reach the blood, possibly induce the formation of immune complexes eventually depositing in the mesangium for some still unknown reason.
In any case, these results provide a theoretical support to the therapeutic tonsillectomy proposed by some authors (14, 15) . Empirical reasons only had been advanced so far, but there seems to be some good to expect from the removal of a dysfunctioning tissue, although it certainly is not the only one implied.
